INCAKE
INCAKE
Industry:
E-Commerce Food And Beverage Food Processing
Founded:
2012-12-27
Address:
Zhabei, Shanghai, China
Country:
China
Website Url:
http://www.incake.net
Total Employee:
251+
Status:
Active
Contact:
400-921-5757
Total Funding:
47.49 M CNY
Technology used in webpage:
IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Domain Not Resolving Euro ASP.NET Apple Mobile Web App Capable IIS Pound Sterling ASP.NET 4.0
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Essence Securities
Essence Securities investment in Post-IPO Equity - INCAKE
Intelligent Capital
Intelligent Capital investment in Post-IPO Equity - INCAKE
Shenwan Hongyuan
Shenwan Hongyuan investment in Post-IPO Equity - INCAKE
Huafu Securities Co., Ltd.
Huafu Securities Co., Ltd. investment in Post-IPO Equity - INCAKE
Intelligent Capital
Intelligent Capital investment in Series A - INCAKE
Huahan Chuang Tou
Huahan Chuang Tou investment in Series A - INCAKE
Broad Resources
Broad Resources investment in Series A - INCAKE
Shenzhen Capital Group
Shenzhen Capital Group investment in Angel Round - INCAKE
Huahan Chuang Tou
Huahan Chuang Tou investment in Angel Round - INCAKE
Official Site Inspections
http://www.incake.net
- Host name: 43.254.54.229
- IP address: 43.254.54.229
- Location: China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "INCAKE"
About us - INCATE
INCATE was founded to help meet the challenge of Antimicrobial Resistance (AMR).INCATE is a unique not-for-profit organization that brings together translational and basic research, industry, experienced entrepreneurs and …See details»
INCATE Portfolio - INCATE
INCATE Portfolio AP 2024-10-28T10:00:16+01:00. Currently active ventures at INCATE. Arivin therapeutics. Tackling resistant infections with virulence inhibition. Website. INVITRIS.See details»
INCATE - LinkedIn
INCATE - INCubator for Antibacterial Therapies Europe – is a partnership which brings together translational and basic research, industry, experienced entrepreneurs and investors from across ...See details»
INCATEurope Overview | SignalHire Company Profile
INCATE - INCubator for Antibiotic Therapies Europe supports innovators to fight drug resistant bacterial infections. Organization Website: incate.net : INCATEurope industries Healthcare …See details»
INCATE marks its third anniversary of successfully supporting ...
Sep 2, 2024 INCATE (the INCubator for Antibacterial Therapies in Europe) is celebrating its third anniversary. Since its launch in August 2021, INCATE has been dedicated to supporting early …See details»
INCATE receives Lighthouse Award 2024 from Swiss National S…
Jun 28, 2024 The SNSF and NCCR AntiResist Management supported INCATE’s creative design and implementation from its inception, with the objective of creating an international …See details»
Needles and haystacks: Preclinical antibacterial pipeline review
Jul 29, 2024 INCATE (Incubator for Antibacterial Therapies in Europe) is an early-stage funding vehicle supporting innovation vs. drug-resistant bacterial infections. The fund provides advice, …See details»
INCATE receives Lighthouse Award 2024 from Swiss National …
Photos: NCCR AntiResist. June 28 th 2024 – INCATE, the INCubator for Antimicrobial Therapies in Europe, has been honored with the 2024 Lighthouse Award for outstanding Transfer of …See details»
BARDA seeks deep insight on antibacterials near/beyond end-of …
Nov 5, 2024 INCATE (Incubator for Antibacterial Therapies in Europe) is an early-stage funding vehicle supporting innovation vs. drug-resistant bacterial infections. The fund provides advice, …See details»
Antibiotic Resistance Funding Calls - AMR.Solutions
Mar 6, 2024 INCATE (Incubator for Antibacterial Therapies in Europe) is an early-stage funding vehicle supporting innovation vs. drug-resistant bacterial infections. The fund provides advice, …See details»
INCATE: a partnership to boost the antibiotic pipeline - Nature
INCATE, the INCubator for Antibacterial Therapies in Europe, aims to boost the antibiotic pipe- line by accelerating the translation of academic innovation into industrial R&D projects to tackle ...See details»
Advancing global antibiotic research, development and access
Sep 3, 2024 Tackling antimicrobial resistance will require a sustainable research and development ecosystem for antibiotic development, alongside strategies for responsible use …See details»
INCATE - Leibniz-HKI
INCATE is a new, virtual and the only European based not-for-profit partnership supporting specifically antimicrobial resistance (AMR)-related innovations (TRL 1-4). INCATE addresses …See details»
Implementation Handbook on National Action Plans from WHO
Mar 3, 2022 Current funding opportunities (most current list is here): [NEW] ICARS– and IDRC-sponsored RFP on gender inequality in AMR (with a focus on sub-Saharan Africa) for …See details»
Phage Therapy: What’s New and What’s Next? – Speakers Biography
Organization: ETH Zürich Alexander Harms has studied antibiotic resilience since his doctoral work at the University of Basel and as a PostDoc at the University of Copenhagen. After his …See details»
Start-ups against AMR: Leibniz-HKI and partners celebrate 3…
Sep 2, 2024 As one of the founding institutions, the Leibniz-HKI is happy to announce that INCATE (the INCubator for Antibacterial Therapies in Europe) is celebrating its third …See details»
WHO Tripartite Joint Secretariat on AMR seeks consultant to …
Oct 23, 2021 The Tripartite Joint Secretariat on AMR consolidates cooperation between the Food and Agriculture Organization (FAO) of the United Nations, the World Organisation for …See details»
Log in to your Okta org
If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, Okta.com, and much more.See details»
WHO Essential Medicines List (EML): Antibiotic Book
[NEW] 30 Nov-1 Dec 2021 (virtual, 10a-3.30p EST on both days): US PACCARB (Presidential Advisory Council on Combatting Antimicrobial Resistant Bacteria) is holding a 2-day meeting …See details»